FOXM1-E2F1 activation not only modulates mitotic fidelity and SASP but also improves the proliferative capacity of high passage cells rather than clearing senescent cells, effectively managing not only the detrimental but also the beneficial (wound healing and tumor suppression) effects of senescence. The gene discussed is E2F1; the disease is neoplasm.